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Abstract: 
Purpose: To determine substrate utilization and energy expenditure during maximal and 
submaximal exercise and recovery in adolescents with cystic fibrosis (CF) and healthy age-
matched controls (C). 
 
Methods: Ten clinically stable CF patients (four girls, six boys; age = 10-22 yr) were matched by 
body mass index, age, gender, and Tanner stage to healthy controls. Subjects completed V·O2peak 
testing and submaximal exercise (20 min) on a cycle ergometer at a relative intensity of 50% 
V·O2peak and at an absolute power output (PO). Metabolic parameters were assessed during 
exercise and recovery (20 min). 
 
Results: Similar respiratory quotient (RQ) values occurred in both groups during maximal 
exercise and recovery, despite differences in the maximal PO [CF = 114 (60-180) W and C = 
171 (105-280) W, P = 0.006], the total work completed [CF = 27 (9.0-54.3) kJ and C = 55 (25.3-
126.5) kJ, P = 0.008], or the V·O2peak value attained [CF = 30.6 (8.5-45.2) mL·kg
-1
·min
-1
 and C = 
40.6 (29-64.5) mL·kg
-1
·min
-1
, P = 0.027]. Submaximal exercise at the same absolute PO resulted 
in similar RQ values during exercise and recovery despite higher heart rates and average V·O2 
[CF = 18.8 (9.3-28.7) mL·kg
-1
·min
-1
 and C = 15.2 (6.5-20.1) mL·kg
-1
·min
-1
, P = 0.031] values in 
CF adolescents, and submaximal exercise at the same relative intensity also resulted in similar 
RQ values despite significantly greater average PO in the C group [CF = 38.7 (12.3-80) W and C 
= 67.8 (25.5-140) W, P = 0.039]. Excess postexercise oxygen consumption (EPOC) was greater 
in CF [2.79 (1.14-5.24) L O2] than C [1.46 (0.56-2.80) L O2] after submaximal exercise at a 
fixed PO (P = 0.036) but not after the relative exercise bout. 
 
Conclusions: Habitual physical activity participation does not warrant adjustment of 
macronutrient intake ratios in adolescents with mild to moderate CF, but total caloric intake may 
need to be increased based on the level of EPOC and upon the intensity and the duration of the 
habitual activity. 
Article: 
Cystic fibrosis (CF) is an inherited, autosomal recessive, multisystem, progressive disease with 
an estimated median lifespan of approximately 40 yr (43). Survival for individuals with CF has 
consistently improved since the 1960s (13), and today patients with mild lung disease comprise 
an increasing percentage of individuals with CF (9). Secretions in all exocrine glands are 
thickened, resulting in pulmonary infection and pancreatic insufficiency (16). Blocked pancreatic 
ducts lead to malabsorption and malnutrition, and glucose intolerance may occur with increasing 
age during adolescence (16). Due to the improvements in therapy, growth retardation and 
wasting in patients with CF have been significantly reduced, but suboptimal nutrition is still a 
common clinical problem (1). Malnutrition in CF patients has been associated with lower 
breathing duty cycles during maximal exercise (15) and likely contributes to reduced physical 
activity (PA) and increased mortality (32). In patients with significant lung disease (forced 
expiratory volume in 1 s (FEV1) <75%), Boucher et al. (4) found that time spent being active 
was significantly related to nutritional status, and other studies have shown that exercise capacity 
in CF may be limited by nutritional status and lung function (18,36,37,44). Several studies 
suggest that intrinsic changes in metabolic and functional muscle characteristics can be observed 
in CF patients, and these changes may or may not be linked to nutrition (25,35). As observed in 
healthy children, individuals with CF are most active during childhood and PA declines with age 
(5). Because exercise capacity may be limited in CF patients, they are particularly prone to a 
negative feedback loop involving compromised exercise capacity, inactivity, and deconditioning 
(36). 
 
Quality of life and likelihood of survival are greater in CF patients with higher levels of aerobic 
fitness (23,28,31,42). Exercise has many beneficial effects for CF patients, including clearing the 
airway mucous (21) and stimulating the release of anabolic mediators (45). Exercise programs 
have been shown to improve pulmonary function and exercise capacity in individuals with CF, 
regardless of whether the programs are structured and supervised or unsupervised (home-based 
programs) (7,22,30,34,42). PA is recognized as an important therapeutic modality for CF 
patients, and many physicians view exercise as important for their patients and advise them to 
exercise (2). Optimizing nutritional status may be one mechanism to help offset the difficulties 
associated with regular participation in exercise and to help maintain PA levels in CF patients as 
they mature. 
 
Resting energy expenditure (REE) has been reported to be elevated in CF patients by some 
researchers (1,33,39,41,46,47), but not others (14,19,35,48). Studies assessing energy 
expenditure (EE) during exercise have also produced mixed results, with some studies reporting 
greater exercise EE for CF patients (11,33), some reporting similar exercise EE (41,48), and one 
study reporting that the energy cost of activity was lower for CF patients than for controls (14). 
Interestingly, one study attributed the increased cost of exercise EE to increased REE (11), 
whereas Richards et al. (33) disagreed. However, studies directly assessing macronutrient 
utilization during rest, exercise, and recovery from exercise in patients with CF are very limited. 
Substrate utilization [from respiratory quotient (RQ) values] was found to be similar for healthy 
controls and patients with CF by one group (48), but another study reported greater RQ values in 
CF patients at rest and during exercise (41). This type of information is important because 
malnutrition can be problematic for these individuals and proper nutrition is important for 
optimal performance of habitual PA. Thus, although PA and exercise participation are helpful in 
managing the disease, maintaining an adequate intake of macronutrients to fuel participation is 
an important issue. What remains unclear is whether alterations in fat and carbohydrate (CHO) 
utilization occur in response to usual daily PA (submaximal exercise) in CF adolescents 
compared with healthy controls. Thus, the purpose of this study was to determine the substrate 
utilization and the energy requirements during and after maximal and submaximal constant load 
exercise and recovery in adolescents with CF and healthy age-matched controls. We 
hypothesized that adolescents with mild CF would not have significantly different substrate 
utilization compared with controls during any of the exercise bouts. 
 
METHODS 
Subjects and Design 
Approval for all procedures was obtained from the institutional review boards of the University 
of North Carolina-Greensboro (UNCG) and the Wake Forest University Baptist Medical Center 
(WFUBMC), the Wake Forest University General Clinical Research Center (GCRC) Scientific 
Advisory Committee, and the WFUBMC Radiation Safety Committee. All procedures were 
initially tested on four healthy adolescents to ensure that instructions and directions were age 
appropriate. Twenty subjects [10 CF (4 girls and 6 boys) and 10 healthy matched controls (C) (4 
girls and 6 boys)] aged 10-22 yr completed the study. Subjects with CF were recruited from the 
CF center at WFUBMC (with the assistance of Michael Schechter, MD). The study was 
restricted to CF patients who had mild to moderate (FEV1% >=40%) pulmonary disease and/or 
exocrine pancreatic disease (treated with vitamin supplements and pancreatic enzymes). Patients 
were excluded if they had 1) heart problems, 2) untreated, elevated nonfasting blood glucose or 
CF-related diabetes, or 3) a positive pregnancy test. Patients with CF were also excluded if they 
had 4) FEV1% <40% predicted, 5) needed oxygen (O2) therapy, 6) active lung infection or 
treatment with intravenous antibiotics within the past month, or 7) were on the lung transplant 
list or had a lung transplant. A power analysis to calculate sample size for the study was chosen 
to detect a relative difference similar to that observed in CF adults by Ward et al. (48) and 
suggested a sample size of 12 subjects per group. The total number of CF patients in the CF 
center meeting the criteria for the study numbered 33; only 10 individuals agreed to participate in 
the study, a 30% recruitment rate. A cross-sectional, case-control design was used to compare 
the CF subjects to 10 C, matched by body mass index (BMI), age, gender, and pubertal stage and 
recruited from the Piedmont area. 
 
A letter and a copy of the consent form were mailed to the family. Approximately 1 wk after the 
mailing, the parents and the child were called at home to answer questions, to determine interest 
in participating, and to schedule a time for testing. Parental informed consent and subject assent 
were obtained for each subject before data collection. All subjects were given a copy of the 
signed forms for their records. The following demographic measures were assessed: 1) pubertal 
stage-Tanner staging using two self-report gender-specific developmental scales for genital hair 
growth and penile or breast development (24); 2) daily PA using the Previous Day Physical 
Activity Recall (PDPAR) questionnaire (50); and 3) current health status using a brief medical 
history and physical screening. 
 
Procedures 
All data collection and exercise testing were completed at the GCRC at WFUBMC for the CF 
subjects. This facilitated enrollment and physician supervision during exercise testing. All testing 
of healthy adolescents was completed at the Exercise Physiology Laboratory at UNCG, except 
for the dual energy x-ray absorptiometry (DXA), which was completed at WFUBMC. 
 
Data were collected during one session that lasted 7-8 h, largely because many subjects travelled 
considerable distances to participate in the study. Subjects ate a standardized light breakfast 
before arriving for testing. They completed a detailed medical history, and vital signs were 
measured. Nonfasting blood glucose was measured in CF subjects only using a finger prick (Life 
Scan Sure Step Flex; Johnson & Johnson, New Brunswick, NJ). Screening blood glucose was 
normal (mean = 90 mg·dL
-1
, range = 75-116 mg·dL
-1
) in all but one subject; the elevated glucose 
was treated and data collection was completed once blood glucose was normal. In addition, a 
urinary pregnancy test was completed on all female subjects who had reached menarche. Daily 
physical activity (PA) was measured using the PDPAR and scored accordingly (50). Briefly, 
subjects listed all activities, including sleep that occurred during 33 half-hour periods for the 
previous day and evening. Subjects also indicated how they perceived the PA in each period: 1) 
light, 2) moderate, 3) hard, or 4) very hard. An average daily PA score, ranging from 1 to 4, was 
calculated for each subject. The procedures and timing for data collection are outlined below, 
and the order of testing was arranged to maximize the time between the peak exercise testing and 
the submaximal exercise testing. 
 
Body composition assessment. 
Subjects had an accurate height (stadiometer) and weight (scale accurate to 0.1 kg) measured, 
and body mass index (BMI) was calculated from these measures. Dual energy x-ray 
absorptiometry (DXA) was completed to determine bone density and percent body fat using a 
Hologic Delphi A (Bedford, MA). 
 
Resting metabolic rate. 
At least 2 h after eating breakfast, subjects rested on a hospital bed in a quiet room for 30 min. 
Resting metabolic rate was measured for 30 min using continuous, computerized open-circuit 
indirect calorimetry (Sensormedics
®
 Vmax229, Yorba Linda, CA). 
 
Peak aerobic capacity. 
A resting, supine ECG was obtained with a Quinton 710 ECG. Aerobic capacity was assessed 
using a Lode (Excalibur
®
, Netherlands) electronically braked cycle ergometer starting with a 2-
min warm-up at 0 W. Initial power output (PO) was determined by height (10) and increased 10 
W every minute until volitional fatigue or decreased oxygen saturation (O2sat; <85%). Subjects 
completed a 2-min cool down at the PO of their choice and then sat quietly in a chair next to the 
bike for the remaining recovery measurements. Oxygen (O2) consumption, carbon dioxide (CO2) 
production, and respiratory quotient (RQ) were measured throughout the test using open-circuit 
spirometry (Sensormedics
®
 Vmax229). Total energy expenditure (EE) was calculated during 
exercise and 20 min of recovery by summing the O2 consumed each minute and multiplying by 
the standard conversion of 5 kcal·L
-1
 of O2 consumed to get total caloric expenditure. Heart rate 
was measured throughout exercise and recovery, and RPE was recorded at the end of each 
minute of exercise. Total work was calculated as the sum of the Watts completed per minute 
during the maximal exercise test and converting this value to kilojoules using standard 
conversions (20). PO for the submaximal exercise sessions was determined by calculating 50% 
of the V·O2peak value. Once this value was obtained, the PO that produced this V·O2 value was 
determined, and this PO was used in the relative submaximal exercise session. Respiratory 
equivalents (V·E/V·O2 and V·E/V·CO2) were calculated and graphed for the first five stages of 
maximal exercise only because stages beyond this point had only a few subjects. 
 
Relative submaximal exercise session. 
Approximately 2 h after eating a standardized snack and 2-3 h after the peak exercise test, a 
constant load submaximal exercise test was done using a Lode Excalibur
®
 electronically braked 
cycle ergometer. The test began with a 2-min warm-up at 0 W, with an increase in PO that was 
calculated to produce 50% V·O2peak from the peak aerobic exercise test. Subjects exercised for 20 
min or until a decrease in oxygen saturation (O2sat; <85%) occurred. When necessary, PO was 
decreased so that subjects could exercise for 20 min. Reductions in PO were necessary in three 
CF subjects and three C subjects, with an average reduction of 10-15 W for both groups. One 
subject had difficulty maintaining an even pedaling cadence, which resulted in widely varying 
V·E and V·O2 values from minute to minute, and the data for this subject were eliminated from 
the analyses related to these measures. Heart rate was measured throughout the exercise and 
recovery, and RPE was noted at 1, 5, 10, 15, and 20 min of exercise. Exercise and recovery O2 
consumption, CO2 production, ventilation, and RQ were measured using open-circuit spirometry 
(Sensormedics
®
 Vmax229). Upon completion of the 20-min exercise session, subjects were 
immediately moved to a chair and were asked to rest quietly for the recovery measurements. The 
percentages of fat and CHO utilization were calculated using standard nonprotein RQ conversion 
tables for the exercise and the recovery data (20). The average PO was calculated as total work 
divided by 20 min. Calculations of excess postexercise oxygen consumption (EPOC) were made 
as described by Short and Sedlock (40), with consideration for resting O2 consumption. 
Respiratory equivalents (V·E/V·O2 and V·E/V·CO2) were calculated and graphed for minutes 1, 
5, 15, and 20. 
 
Absolute submaximal exercise session. 
On a separate occasion, 7 of the 10 healthy, age-matched control subjects returned to the 
Exercise Physiology Laboratory at UNCG to complete a second submaximal exercise test. At 
least 2 h after eating a standardized snack, subjects completed a 2-min warm-up at 0 W, and then 
PO was increased to the same level as that of the CF patient who was matched to the control. 
This second submaximal exercise session allowed us to address differences in substrate 
utilization between the two groups at the same absolute workload. 
 
Pulmonary function tests (PFT). 
Severity of pulmonary disease was measured by PFT, obtained according to American Thoracic 
Society guidelines by trained spirometry technicians every 3 months for all patients in the CF 
center as part of routine medical care. The Knudsen Regression Equation in the computerized 
database accounted for gender, racial, height, and weight differences in calculating PFT. 
Pulmonary function chart data from the last clinic visit (within the past 3 months) were used to 
classify severity of pulmonary disease. The specific PFT used were 1) percent predicted FEV in 
the first second (FEV1% predicted), 2) forced vital capacity (FVC% predicted), 3) FEV1-FVC 
ratio, and 4) FEF25-75 (FEF25-75% predicted), forced expiratory flow from 25% to 75% of FVC% 
predicted. PFT and MVV were assessed on the day of testing with the Sensormedics
®
 Vmax229 
gas analyzer in all subjects. Oxygen saturation (O2sat) was obtained using a pulse oximeter; CF 
subjects were monitored continuously for O2sat throughout the exercise testing. 
 
Statistics 
Descriptive statistics and exercise data presented include the mean (range). CF and matched 
normal controls were compared using the Wilcoxon signed rank test as the differences were 
usually not normally distributed. Statistical significance was set at P < 0.05, but no adjustment 
for multiple comparisons was made. The P values are reported as a form of descriptive statistics. 
 
RESULTS 
Subject characteristics are shown in Table 1. Groups were matched on age and Tanner stage, but 
adolescents with CF were significantly smaller (height and weight) than the healthy adolescents 
despite similar BMI values. Although smaller height and weight could indicate potential growth 
delays or inadequate nutrient absorption in the CF group, this was not reflected by percent body 
fat values, which were similar for both groups [18.2% (10.6-25.1%) vs 20.7% (12.9-31.1%) for 
CF and C, respectively, P = 0.33]. No difference in pubertal development was present as 
measured by the self-report Tanner scale, and REE was similar for both groups. Both groups 
reported moderate daily PA from the PDPAR assessment [2.03 (1.39-3.95) and 2.06 (1.57-3.18) 
for CF and C, respectively, P = 0.49]. 
 
 
 
Comparisons of the PFT are also presented in Table 1. Mean FEV1% predicted for the CF group 
was 77.5%, indicating mild CF [four had FEV1% >40-69%, four had FEV1% 70% to <90%, and 
two had normal lung function]. Control subjects had no known lung disease, but four had 
reduced FEV1% (70-87%), likely due to inexperience with performing PFT. The 13.5% mean 
difference in FEV1% between groups was not significant, but the range within the CF group was 
nearly twice that of the C group. Breathing reserve index at maximal exercise (BRImax; 
V·Emax/MVV) was similar for the two groups [0.70 (0.46-1.01) compared with 0.69 (0.41-0.92) 
for CF and C, respectively, P = 0.98]. 
 
The results from the peak aerobic capacity testing are presented in Table 2. As expected, CF 
patients were significantly more unfit than the C group, with lower maximal PO, total work, total 
exercise energy expenditure (EE), and V·O2peak values expressed in either milliliters per kilogram 
per minute [30.6 (8.5-45.2) vs 40.6 (29-64.5) mL·kg
-1
·min
-1
, P = 0.027] or liters per minute [1.33 
(0.43-2.37) vs 2.09 (1.15-3.96) L·min
-1
, P = 0.004]. Maximal and recovery RQ values were 
similar in the two groups. Blood pressure and RPE responses were also similar for the groups, 
but heart rate and time to reach resting V·O2 during recovery were significantly greater in the C 
group. 
 
 
 
Figure 1 demonstrates the O2 consumption patterns for the CF group and for the C group during 
the relative and the absolute submaximal exercise testing sessions and for the 20 min of recovery 
from submaximal exercise. The pattern of O2 consumption was similar for all exercise sessions, 
and although O2 consumption was greater during recovery in the CF subjects, the pattern was 
similar to that observed for the C group. Calculations of total O2 consumed during recovery (L 
O2) revealed that both groups had similar EPOC after the relative submaximal exercise session 
[2.7 (1.95-5.24) and 2.1 (1.39-3.24) L O2; P = 0.16] (Table 3), but that EPOC was significantly 
greater in the CF group after the absolute submaximal exercise session [2.79 (1.14-5.24) vs 1.46 
(0.56-2.80) L O2, P = 0.036] (Table 4). 
 
 
FIGURE 1-Profiles of O2 consumption (V·O2) during 20 min of submaximal exercise and 20 min 
of recovery in patients with CF (solid circles) and at the same relative intensity (50% V·O2peak) in 
controls (solid squares) and with controls working at the same absolute PO (solid triangles). 
Mean resting V·O2 values are shown for CF (dotted line) and controls (solid line). Values are 
presented as mean ± SD. 
 
TABLE 3. Submaximal exercise and recovery results for the adolescents with cystic fibrosis 
(CF) and healthy, matched controls (C) when relative intensity was set at 50% of V·O2peak. 
 
TABLE 4. Submaximal exercise and recovery results for the adolescents with cystic fibrosis 
(CF) and healthy, matched controls (C) when PO was set at the same absolute level. 
 
Table 3 provides more detailed data on submaximal exercise and recovery when relative 
intensity was set at 50% V·O2peak. The two groups had similar maximal heart rate, blood 
pressure, and RPE responses during the 20-min constant load submaximal exercise session. 
When both groups performed the same relative intensity, the C group maintained a higher 
average PO and expended more energy over the 20 min of exercise and, thus, completed 
significantly more work [81.7 (30.7-167.7) vs 46.6 (14.8-96.4) kJ, P = 0.039]. Although the C 
group had higher V·O2 values measured in liters per minute and milliliters per kilogram per 
minute, the differences were not significant (P = 0.13 and 0.49, respectively). Although the C 
group maintained a higher average PO and expended more energy during exercise, the average 
RQ values were similar for both groups during exercise and at 5 and 20 min of recovery. The 
time to return to resting V·O2 values was also similar for the two groups. Interestingly, although 
the PO for the submaximal exercise session was chosen to elicit O2 consumption values equal to 
50% of V·O2peak in both groups, the CF group worked at slightly higher average values [60.3% 
(50.1-69.4%) vs 53.2% (40.0-67.5%), P = 0.12]. 
 
When PO was set at the same absolute levels (Table 4), CF individuals required higher heart 
rates and relative O2 consumption to complete the submaximal exercise session. Total work 
completed was similar for the CF [41.2 (14.8-96.4) kJ] and C [46.1 (14.7-96.4) kJ] (P = 0.88), 
but average O2 consumption was less for the C group to complete the same absolute PO (P = 
0.016). Although the CF subjects worked at a greater percent of their V·O2peak [66.8% (50.1-
69.4%) vs 42.7% (19.1-68.3%), P = 0.016], the CF and the C groups had similar RPE, BP, total 
exercise EE, and RQ values, and there was no difference in the time to reach resting O2 
consumption. 
 
Ventilatory equivalents for O2 and CO2 during the first five stages of the maximal exercise are 
shown in Figure 2. V·E/V·O2 was significantly greater in the CF group during stage 4 only [36.1 
(25.7-46.0) vs 29.9 (22.8-35.3) for CF and C, respectively, P = 0.031], and V·E/V·CO2 was 
significantly greater in the CF group during stage 2 only [39.0 (30.5-48.8) vs 34.2 (27.9-43.7) for 
CF and C, respectively, P = 0.018]. Figure 3 shows the ventilatory equivalents for O2 and CO2 
during the relative submaximal exercise bout. The V·E/V·O2 was not different between the two 
groups, and V·E/V·CO2 was significantly greater in the CF group only for the first minute of 
exercise [36.9 (27.6-42.6) vs 31.3 (26.5-38.0) for CF and C, respectively, P = 0.031]. 
 
 
FIGURE 2-Ventilatory equivalents for O2 calculated as V·E/V·O2 (A) and CO2 calculated as 
V·E/V·CO2 (B) during the first five stages of the V·O2peak test for CF (solid circles) and controls 
(solid squares). Values are presented as mean ± SD. *P < 0.05. 
 
 
FIGURE 3-Ventilatory equivalents for O2 calculated as V·E/V·O2 (A) and CO2 calculated as 
V·E/V·CO2 (B) for CF (solid circles) and controls (solid squares) during the relative submaximal 
constant load exercise test. Values are presented as mean ± SD. *P < 0.05. 
 
DISCUSSION 
This study found that 1) similar RQ values and, therefore, similar CHO and fat utilization occur 
during maximal exercise and recovery in C and CF adolescents despite differences in the 
maximal workload attained, the total work completed, the total energy expended, or the V·O2peak 
value attained; 2) short duration submaximal aerobic exercise (20 min on a cycle ergometer) at 
the same relative intensity (50% V·O2peak) resulted in similar RQ values (similar CHO and fat 
utilization) during exercise and recovery for both CF and C; and 3) during short duration 
submaximal aerobic exercise (20 min on a cycle ergometer), at the same absolute power output 
(PO) as C adolescents, CF individuals had higher heart rates, higher V·O2 values (mL·kg
-1
·min
-1
) 
during exercise, and higher excess postexercise oxygen consumption (EPOC) despite similar 
exercise EE and CHO and fat utilization during exercise and recovery. 
 
Similar to Ward et al. (48), our study indicates that CHO and fat utilization and EE are similar 
during exercise in CF patients with mild to moderate disease and healthy, matched control 
adolescents. During maximal exercise, submaximal exercise at a fixed relative intensity, and 
submaximal exercise at a fixed absolute PO, the CF and the C groups had similar RQ values and, 
thus, similar CHO and fat utilization. Although Ward et al. (48) did not specifically measure 
EPOC, they found significantly higher EE (kJ·min
-1
) after a submaximal exercise session at a 
fixed absolute PO in CF adults compared with control subjects. We also noted significantly 
greater EPOC during recovery from submaximal exercise at a fixed absolute workload in the CF 
adolescents compared with the C group. The magnitude of EPOC measured in our study was 
similar to that reported by Short and Sedlock (40) after submaximal exercise bouts at a fixed 
absolute intensity in trained versus untrained individuals. In the current study, CF and C 
individuals had similar average PO, total exercise EE, and total work during the exercise bout 
with a fixed absolute intensity, but CF individuals had higher heart rates, had average V·O2 
(mL·kg
-1
·min
-1
), and were working at a higher percentage of their V·O2peak. Although the 
magnitude of EPOC is determined by many factors, elevation in heart rate is a known contributor 
(20). 
 
Spicher et al. (41) reported significantly greater RQ values and, thus, higher CHO utilization 
during submaximal exercise at set workloads in CF subjects (age 8-24) than in controls. 
However, these results must be interpreted with caution because maximal exercise testing was 
not completed and the intensity of effort for each group could not be determined. Intensity of 
effort is known to influence macronutrient utilization: increasing intensity (% V·O2peak) results in 
greater CHO utilization (6). When individuals are given an identical exercise task (workload or 
PO is set at a constant level), the task will represent varying levels of exercise intensity for the 
individuals, and this difference will greatly influence macronutrient substrate utilization. Results 
from the current study clearly demonstrate this. When both groups completed the same absolute 
PO for 20 min, the effort was significantly less strenuous for the C group (~47% V·O2peak) than 
the CF group (~60% V·O2peak). Although the CF group had a slightly higher RQ (0.93 vs 0.90), 
the difference was not significant. A more taxing workload or a longer exercise bout might have 
resulted in significantly greater RQ values simply due to the increased intensity of effort in the 
CF group. 
 
We also had both groups complete a submaximal exercise session at the same relative intensity 
(50% V·O2peak) to allow us to directly compare macronutrient substrate utilization at the same 
intensity of effort. In this situation, RQ values were almost identical for the two groups although 
the C group had higher average PO and greater exercise EE. Although exercise at the same 
relative intensity allows unbiased comparison of RQ, it does not represent a free-living situation. 
To prescribe exercise at a relative intensity, a measure or prediction of maximal O2 consumption 
must be done. Subjects must also be provided with a corresponding heart rate range and an 
accurate way to measure heart rate to ensure they are exercising at the proper intensity level. A 
controlled, clinical exercise intervention is the ideal situation, but it is not realistic for most 
adolescents. Instead they are asked to "keep up with their peers" on the soccer field, the 
basketball court, or the track. They must perform at the same absolute workload to be 
competitive with their peers. 
 
To investigate the possible role of ventilation in limiting the exercise performance of CF 
individuals in the current study, we calculated the breathing reserve index at maximal exercise 
(BRImax) and the ventilatory equivalents for O2 (V·E/V·O2) and CO2 (V·E/V·CO2). In general, the 
maximal exercise ventilation (V·E) represents 50-80% of MVV, and most of our subjects fell 
within this range. A high BRImax suggests a low breathing reserve and indicates that exercise 
capacity may be limited by ventilatory capacity (37,49). In the current study, ventilation does not 
appear to have limited maximal exercise performance for most subjects because BRImax was 
within the normal range. During maximal exercise testing, both the CF and the C group had 
similar responses for ventilatory equivalents, but as noted in a previous study (14), the values 
were greater in the CF patients. As outlined by Wasserman et al. (49), V·E/V·CO2 decreased 
during the first few stages and V·E/V·O2 remained stable and then increased (Fig. 2), a specific 
demonstration that the anaerobic threshold has been passed. This occurs earlier in the CF group 
compared with the C group. We also calculated the ventilatory equivalents during the relative 
submaximal exercise session (50% V·O2peak) and observed that the values were greater for the CF 
group compared with the C group at all time points, but this difference was significant only for 
V·E/V·CO2 during the first minute of the constant load exercise test. Interestingly, the ventilation 
and the V·CO2 values were significantly greater in the C group during this first minute, but the 
ratio was significantly lower in the C group. We speculate that this finding is related to slower O2 
uptake kinetics that has been noted in CF subjects during activity transitions (12). 
 
Some studies have reported increased REE in CF patients (1,11,33,39,41,46,47), whereas others 
have not (14,19,35,48). There are many possible reasons for these inconsistent results, including 
whether the groups were matched, what criteria were used to match groups, and how severe the 
disease was in CF patients. In the present study, we did not find differences in REE, even when 
we controlled for FFM [REE/FFM (P = 0.139) or REE/[square root]FFM (P = 0.441); data not 
reported for these variables]. This is probably because patients in the study had only mild to 
moderate CF (FEV1% was >40% predicted) and many had PFT that were only slightly lower 
than normal. Thus, the metabolic cost of ventilation for these individuals was probably not 
significantly elevated above that for the C group. In addition, we matched our subjects on many 
variables, including BMI, age, gender, and pubertal stage. The significance of pubertal stage 
matching should not be underestimated in this population because similar biological age does not 
always equate to similar developmental stage. 
 
In our study, the V·O2peak values were approximately 10 mL·kg
-1
·min
-1
 lower in the CF group 
than in the C group, indicating lower levels of aerobic fitness in the CF group. The maximal O2 
consumption values obtained by our C group were similar to the values published by Nixon and 
Orenstein (27), and the values obtained by our group of CF patients were slightly below the 
average reported by some investigators (28,31) but similar to the average reported by others 
(17,38). Several studies have shown that peak O2 uptake is related to both FEV1% predicted (28) 
and mortality in individuals with CF (23,28,31,42). Only one of our CF subjects had a V·O2peak 
value >45 mL·kg
-1
·min
-1
 and six subjects had V·O2peak values <32 mL·kg
-1
·min
-1
. Interestingly, 
several studies (17,31) have shown that CF individuals with similar disease severity (as assessed 
by FEV1) have different prospects of survival depending on their V·O2peak values. Thus, the 
V·O2peak values of six of our CF patients indicate a less than favorable survival outcome (31). 
Although there is a learning effect in the measurement of V·O2peak (31) and subject effort is 
crucial for accurate assessment of V·O2peak, it is unlikely that V·O2peak values would differ 
extraordinarily after multiple attempts. In fact, in the current study, RQ values during maximal 
testing were greater than 1.1 in both groups, a classic indicator of ma ximal effort. It is important 
to remember, however, that effort is only one of many factors that can influence the 
measurement of V·O2peak. Genetics plays a substantial role in determining V·O2peak (3), and the 
genes that result in attainment of higher V·O2peak values may also confer a survival advantage in 
CF (31). In fact, several studies have indicated that exercise performance may be limited in CF 
patients due to secondary pathological changes in skeletal muscle (8), and these have been 
shown to be independent of muscle size (25). 
 
In the current study, we used submaximal constant load exercise testing because it allowed us to 
address the issues of substrate utilization during an activity that was fairly representative of 
activities of daily living (22,26). In addition, submaximal constant load exercise testing may 
have other advantages for CF patients. Submaximal exercise responses are less reliant on 
genetics than V·O2peak, allow assessment of factors that limit exercise performance on a day-to-
day basis (26), may be less risky for CF patients than maximal exercise tests, and are an 
excellent indicator of changes in fitness level with training (22). However, caution is necessary 
in selecting the type of submaximal exercise test that is used because Narang et al. (26) showed 
that short sessions of submaximal exercise, such as the 3-min step test, missed important 
information that might have been revealed by more complex exercise tests. More research is 
needed to explicate whether performance on a submaximal constant load exercise test is 
predictive of survival or linked to mortality in patients with CF. 
 
The current study suggests that adolescent CF patients with mild to moderate disease who are 
habitually participating in PA may not require adjustments in their macronutrient intake ratio 
(CHO vs fat) because their RQ values were similar to control subjects during maximal and 
submaximal exercise and recovery. Although REE and exercise EE were not significantly 
elevated in CF individuals in the current study, the submaximal exercise sessions were of 
relatively short duration (20 min). Increased total caloric intake may be preferential for 
individuals with CF who are habitually participating in PA that requires high-intensity work or 
relatively long durations (45-60 min), which may result in significant EPOC. A recent study by 
Johnson et al. (14) provided CF patients with fat or CHO supplements equaling 50% of their 
REE during a 6-wk supervised exercise program in an effort to manipulate EE. The authors did 
not directly measure activity, all the CF patients received supplementation, and no 
postintervention testing was done to assess improvements in physical capacity (14), so it is 
difficult to discern the role of supplementation for increasing participation in PA for CF patients. 
Clearly, more work is needed in this area. 
 
In summary, although recent data show that lung function is preserved in CF patients who 
participate in regular exercise (22,29), no studies have directly tested the hypothesis that patients 
with CF who remain physically active succeed in delaying the onset of respiratory failure (31). 
Any intervention that improves or at the very least preserves lung function over the long term has 
important implications for disease management (22,29), and exercise programs appear to fulfill 
this role. What remains to be elucidated are the factors that need to be addressed to provide the 
best clinical support for individuals with CF as they pursue increased PA. 
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